Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRAME family member 15 is a protein-coding gene that belongs to the PRAME (Preferentially Expressed Antigen in Melanoma) family, a group of cancer/testis antigens with roles in immunity, germline development, and oncogenesis[9][1][3]. PRAMEF15 enables ubiquitin-like ligase-substrate adaptor activity and functions as a component of the Cullin2-RING E3 ubiquitin ligase complex, involved in protein ubiquitination and proteasomal degradation[1][3]. Its protein domain structure includes leucine-rich repeats, and it may play a part in regulating retinoic acid signaling and nuclear receptor binding (supported by family member studies)[5][3]. PRAME family members are markers of several cancers and have restricted expression in normal adult tissues, mainly testis, with reactivation in various tumors; PRAMEF15 itself is associated with diseases including adult astrocytic tumor and retinitis pigmentosa[3][9]. Though the direct therapeutic targetability of PRAMEF15 is not established, PRAME family proteins are under investigation as immune targets in oncology due to their high tumor specificity and immunogenicity[9][5]. Note: - There are no current reports of approved drugs directly targeting PRAMEF15 or of biomarker or safety issues specific to this member. - Most biological and potential clinical roles are inferred by analogy to the broader PRAME family, as direct functional and mechanistic data for PRAMEF15 are limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRAME family member 15 (PRAMEF15).